Total Payments
$751.58
2024 Payments
$480.70
Companies
12
Transactions
31
Medicare Patients
426
Medicare Billing
$11,363
Payment Breakdown by Category
Food & Beverage$751.58 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $751.58 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $177.70 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $176.75 | 3 | $0 (2024) |
| Lilly USA, LLC | $117.01 | 4 | $0 (2024) |
| Exact Sciences Corporation | $69.28 | 3 | $0 (2024) |
| ABBVIE INC. | $49.08 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $34.82 | 2 | $0 (2023) |
| Amgen Inc. | $33.88 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $22.69 | 1 | $0 (2024) |
| Abbott Laboratories | $21.97 | 1 | $0 (2024) |
| Horizon Therapeutics plc | $17.39 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $480.70 | 17 | AstraZeneca Pharmaceuticals LP ($152.38) |
| 2023 | $131.72 | 7 | Novo Nordisk Inc ($54.46) |
| 2022 | $139.16 | 7 | Novo Nordisk Inc ($48.41) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $54.79 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Oncology | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $109.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Inflammation | ||||||
| 07/22/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: ANTIBIOTIC | ||||||
| 06/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Diabetes Care | ||||||
| 05/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes | ||||||
| 04/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Cardio-renal | ||||||
| 04/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 04/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.15 | General |
| 03/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Oncology | ||||||
| 03/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: VACCINES | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $42.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: KRYSTEXXA | ||||||
| 06/26/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.94 | General |
| 03/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Diabetes | ||||||
| 02/03/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 01/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VACCINES | ||||||
| 10/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 32 | 48 | $12,124 | $2,855 |
| 2022 | 1 | 42 | 42 | $1,638 | $877.04 |
| 2021 | 1 | 246 | 259 | $10,101 | $5,311 |
| 2020 | 2 | 106 | 109 | $5,620 | $2,320 |
Total Patients
426
Total Services
458
Medicare Billing
$11,363
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 26 | $7,592 | $1,825 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 22 | $4,532 | $1,029 | 22.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 42 | 42 | $1,638 | $877.04 | 53.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 246 | 259 | $10,101 | $5,311 | 52.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 93 | 96 | $3,744 | $1,990 | 53.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $1,876 | $330.25 | 17.6% |
About Joy Odafe, NP-C
Joy Odafe, NP-C is a Family healthcare provider based in Humble, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1528480217.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joy Odafe, NP-C has received a total of $751.58 in payments from pharmaceutical and medical device companies, with $480.70 received in 2024. These payments were reported across 31 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($751.58).
As a Medicare-enrolled provider, Odafe has provided services to 426 Medicare beneficiaries, totaling 458 services with total Medicare billing of $11,363. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Humble, TX
- Active Since 01/14/2014
- Last Updated 04/10/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528480217
Products in Payments
- FARXIGA (Drug) $176.75
- MOUNJARO (Drug) $117.01
- Cologuard Collection Kit (Device) $69.28
- Rybelsus (Drug) $54.77
- Ozempic (Drug) $42.21
- UBRELVY (Drug) $35.63
- SHINGRIX (Biological) $34.82
- Otezla (Drug) $33.88
- Kerendia (Drug) $22.69
- FREESTYLE LIBRE 3 (Device) $21.97
- KRYSTEXXA (Biological) $17.39
- PREVNAR 20 (Biological) $15.57
- NUZYRA (Drug) $15.44
- VRAYLAR (Drug) $13.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Humble
Debbie Burkhardt, Fnp, FNP
Family — Payments: $10,525
Family $10,525
Joan Moore
Family — Payments: $10,100
Family $10,100
Rosa Cordova-Lopez
Family — Payments: $7,955
Family $7,955
Brenda Baluyut
Family — Payments: $7,930
Family $7,930
Clive Gomilla, Np-C, NP-C
Family — Payments: $7,507
Family $7,507
Kacy Hincapie, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $7,361
Family $7,361